Evidence map›Paper›PMID 34065943›Full record

ArticleMarine drugs2021

Chitosomes-In-Chitosan Hydrogel for Acute Skin Injuries: Prevention and Infection Control.

Lisa Myrseth Hemmingsen, Kjersti Julin, Luqman Ahsan, Purusotam Basnet, Mona Johannessen, Nataša Škalko-Basnet

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Gels (Basel, Switzerland) · 2025
    Review
  7. Wound Dressing Based on Cassava Silk-Chitosan.Materials (Basel, Switzerland) · 2024
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Applications of Chitosan and its Derivatives in Skin and Soft Tissue Diseases.Frontiers in bioengineering and biotechnology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lisa Myrseth HemmingsenDrug Transport and Delivery Research Group, Department of Pharmacy, University of Tromsø The Arctic University of Norway, Universitetsvegen 57, 9037 Tromsø, Norway.ORCID 0000-0003-0425-8829
Kjersti JulinResearch Group for Host-Microbe Interaction, Department of Medical Biology, University of Tromsø The Arctic University of Norway, Sykehusvegen 44, 9037 Tromsø, Norway.
Luqman AhsanDrug Transport and Delivery Research Group, Department of Pharmacy, University of Tromsø The Arctic University of Norway, Universitetsvegen 57, 9037 Tromsø, Norway.
Purusotam BasnetIVF Clinic, Department of Obstetrics and Gynecology, University Hospital of North Norway, Sykehusvegen 38, 9019 Tromsø, Norway.ORCID 0000-0001-8612-9558
Mona JohannessenResearch Group for Host-Microbe Interaction, Department of Medical Biology, University of Tromsø The Arctic University of Norway, Sykehusvegen 44, 9037 Tromsø, Norway.
Nataša Škalko-BasnetDrug Transport and Delivery Research Group, Department of Pharmacy, University of Tromsø The Arctic University of Norway, Universitetsvegen 57, 9037 Tromsø, Norway.ORCID 0000-0002-4301-2840
UiT The Arctic University of Norway · NOUniversity Hospital of North Norway · NO

Funding

UiT The Arctic University of Norway 235569
6 · The paper itself

Abstract

Burns and other skin injuries are growing concerns as well as challenges in an era of antimicrobial resistance. Novel treatment options to improve the prevention and eradication of infectious skin biofilm-producing pathogens, while enhancing wound healing, are urgently needed for the timely treatment of infection-prone injuries. Treatment of acute skin injuries requires tailoring of formulation to assure both proper skin retention and the appropriate release of incorporated antimicrobials. The challenge remains to formulate antimicrobials with low water solubility, which often requires carriers as the primary vehicle, followed by a secondary skin-friendly vehicle. We focused on widely used chlorhexidine formulated in the chitosan-infused nanocarriers, chitosomes, incorporated into chitosan hydrogel for improved treatment of skin injuries. To prove our hypothesis, lipid nanocarriers and chitosan-comprising nanocarriers (≈250 nm) with membrane-active antimicrobial chlorhexidine were optimized and incorporated into chitosan hydrogel. The biological and antibacterial effects of both vesicles and a vesicles-in-hydrogel system were evaluated. The chitosomes-in-chitosan hydrogel formulation demonstrated promising physical properties and were proven safe. Additionally, the chitosan-based systems, both chitosomes and chitosan hydrogel, showed an improved antimicrobial effect against

Indexed as

Anti-Infective Agents, LocalCell LineChitosanChlorhexidineDrug Delivery SystemsHumansHydrogelsNanogelsNanomedicineSkinSkin Diseases, InfectiousStaphylococcus aureusStaphylococcus epidermidisWound HealingAnti-Infective Agents, LocalChitosanChlorhexidineHydrogelsNanogelsacute wound managementbacterial eradicationchitosan hydrogelchitosan-infused liposomesmembrane-active antimicrobialsStaphylococcaceae

Identifiers

PMID34065943
PMCPMC8150996
OpenAlexW3161127976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.